Alexandria Real Estate Equities
ARE
#2258
Rank
A$11.60 B
Marketcap
A$66.98
Share price
-4.10%
Change (1 day)
-54.54%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -A$1.48 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are A$2.94 Billion. a decrease over its 2024 earnings that were of A$1.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 -A$1.45 Billion-242.13%
2024 A$1.01 B96.11%
2023 A$0.51 B-53.56%
2022 A$1.11 B-3.96%
2021 A$1.15 B-20.26%
2020 A$1.45 B72.88%
2019 A$0.84 B3.11%
2018 A$0.81 B73.54%
2017 A$0.46 B464.88%
2016 A$83.15 M-77.32%
2015 A$0.36 B36.31%
2014 A$0.26 B-10.81%
2013 A$0.30 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.82 B-1,129.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$37.43 B-2,699.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$13.05 B-1,006.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$14.25 B-1,089.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.72 B-219.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.57 B-1,042.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.83 B-158.16%๐Ÿ‡บ๐Ÿ‡ธ USA